FindTrial
Sign In

Understanding spinal cord diseases using MRI

Role of magnetic resonance spectroscopy in spinal cord lesions with clinical and / or histopathological correlation - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/05/067701
Enrollment
33
Registered
2024-05-21
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G959- Disease of spinal cord, unspecified Health Condition 2: G952- Other and unspecified cord compression Health Condition 3: G958- Other specified diseases of spinalcord Health Condition 4: G950- Syringomyelia and syringobulbia Health Condition 5: G951- Vascular myelopathies

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Datta Meghe Institute Of Higher Education And Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with spinal cord lesions on M.R. imaging

Exclusion criteria

Exclusion criteria: Patients with metal implants or foreign bodies in their eyes, pacemakers, Claustrophobic patients, Uncooperative and non-consenting patient.

Design outcomes

Primary

MeasureTime frame
Significant correlation between findings of MR spectroscopy and clinical or histopathological findings of spinal cord lesions.Timepoint: Assessment will be done at the end of 18 months.—

Secondary

MeasureTime frame
nilTimepoint: NA—

Countries

India

Contacts

Public ContactDr Shirish V Vaidya

Datta Meghe Institute of Higher Education and Research

drshirish283@gmail.com7038555648

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026